Zhongguancun: withdraw the registration application for Paracetamol Hydrocodone tablets.

Zhongguancun announcement: Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of the company, has received the "Notice of Termination of Drug Registration Application" issued by the National Medical Products Administration, agreeing to withdraw the registration application for Amfenac Hydroxamic Ketone Tablets.